These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9177171)

  • 1. Evidence for a mediator cycle at the initiation of transcription.
    Svejstrup JQ; Li Y; Fellows J; Gnatt A; Bjorklund S; Kornberg RD
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6075-8. PubMed ID: 9177171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription elongation through DNA arrest sites. A multistep process involving both RNA polymerase II subunit RPB9 and TFIIS.
    Awrey DE; Weilbaecher RG; Hemming SA; Orlicky SM; Kane CM; Edwards AM
    J Biol Chem; 1997 Jun; 272(23):14747-54. PubMed ID: 9169440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation.
    Otero G; Fellows J; Li Y; de Bizemont T; Dirac AM; Gustafsson CM; Erdjument-Bromage H; Tempst P; Svejstrup JQ
    Mol Cell; 1999 Jan; 3(1):109-18. PubMed ID: 10024884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription elongation factor Spt4 mediates loss of phosphorylated RNA polymerase II transcription in response to DNA damage.
    Jansen LE; Belo AI; Hulsker R; Brouwer J
    Nucleic Acids Res; 2002 Aug; 30(16):3532-9. PubMed ID: 12177294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchange of RNA polymerase II initiation and elongation factors during gene expression in vivo.
    Pokholok DK; Hannett NM; Young RA
    Mol Cell; 2002 Apr; 9(4):799-809. PubMed ID: 11983171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA polymerase II general elongation factors.
    Reines D; Conaway JW; Conaway RC
    Trends Biochem Sci; 1996 Sep; 21(9):351-5. PubMed ID: 8870500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of yeast RNA polymerase II holoenzymes.
    Koleske AJ; Chao DM; Young RA
    Methods Enzymol; 1996; 273():176-84. PubMed ID: 8791611
    [No Abstract]   [Full Text] [Related]  

  • 8. TFIIF-TAF-RNA polymerase II connection.
    Henry NL; Campbell AM; Feaver WJ; Poon D; Weil PA; Kornberg RD
    Genes Dev; 1994 Dec; 8(23):2868-78. PubMed ID: 7995524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of RNA polymerase II general transcription factors from rat liver.
    Conaway RC; Reines D; Garrett KP; Powell W; Conaway JW
    Methods Enzymol; 1996; 273():194-207. PubMed ID: 8791613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIIS.
    Wu J; Awrey DE; Edwards AM; Archambault J; Friesen JD
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11552-7. PubMed ID: 8876173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preponderance of free mediator in the yeast Saccharomyces cerevisiae.
    Takagi Y; Chadick JZ; Davis JA; Asturias FJ
    J Biol Chem; 2005 Sep; 280(35):31200-7. PubMed ID: 16002404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the open region of RNA polymerase II transcription complexes in the early phase of elongation.
    Fiedler U; Timmers HT
    Nucleic Acids Res; 2001 Jul; 29(13):2706-14. PubMed ID: 11433015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II.
    Kim YJ; Björklund S; Li Y; Sayre MH; Kornberg RD
    Cell; 1994 May; 77(4):599-608. PubMed ID: 8187178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of transcription factor TFIIF functional domains required for initiation and elongation.
    Tan S; Conaway RC; Conaway JW
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6042-6. PubMed ID: 7597077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual charge configurations in transcription factors of the basic RNA polymerase II initiation complex.
    Karlin S
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5593-7. PubMed ID: 8516305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mammalian SRB protein associated with an RNA polymerase II holoenzyme.
    Chao DM; Gadbois EL; Murray PJ; Anderson SF; Sonu MS; Parvin JD; Young RA
    Nature; 1996 Mar; 380(6569):82-5. PubMed ID: 8598913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a 3'-->5' exonuclease activity associated with human RNA polymerase II.
    Wang D; Hawley DK
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):843-7. PubMed ID: 8381534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation and crystallization of yeast RNA polymerase II elongation complexes.
    Gnatt A; Fu J; Kornberg RD
    J Biol Chem; 1997 Dec; 272(49):30799-805. PubMed ID: 9388221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified yeast RNA polymerase II reads through intrinsic blocks to elongation in response to the yeast TFIIS analogue, P37.
    Christie KR; Awrey DE; Edwards AM; Kane CM
    J Biol Chem; 1994 Jan; 269(2):936-43. PubMed ID: 8288647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.